down arrow

Helius Medical Technologies, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US42328V8019
USD
4.20
0.11 (2.69%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

3.994.35

52 Week

2.831,200.00
Valuation
Technical
Day's Volume

CASH

470.97 k

Shareholding (Mar 2025)

FII

0.02%

Held by 8 FIIs

DII

99.14%

Held by 1 DIIs

Promoter

0.00%

How big is Helius Medical Technologies, Inc.?

22-Jun-2025

As of Jun 18, Helius Medical Technologies, Inc. has a market capitalization of 0.16 million, with net sales of 0.43 million and a net profit of -13.07 million over the last four quarters. The company reported shareholder's funds of 1.06 million and total assets of 3.54 million as of Dec 24.

Market Cap: As of Jun 18, Helius Medical Technologies, Inc. has a market capitalization of 0.16 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Helius Medical Technologies, Inc. reported net sales of 0.43 million and a net profit of -13.07 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 1.06 million and total assets of 3.54 million.

Read More

What does Helius Medical Technologies, Inc. do?

22-Jun-2025

Helius Medical Technologies, Inc. is a micro-cap medical technology company focused on neurological wellness, with recent net sales of $0 million and a net loss of $4 million. The company has a market cap of $0.16 million and operates within the Pharmaceuticals & Biotechnology industry.

Overview: <BR>Helius Medical Technologies, Inc. is a medical technology company focused on neurological wellness, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -4 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 0.16 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.87 <BR>Return on Equity: -1,169.69% <BR>Price to Book: 0.13<BR><BR>Contact Details: <BR>Address: 642 Newtown Yardley Road, NEWTOWN PA: 18940 <BR>Tel: 1 215 9446104 <BR>Fax: 1 302 6555049 <BR>Website: https://heliusmedical.com/

Read More

Is Helius Medical Technologies, Inc. overvalued or undervalued?

25-Jun-2025

Helius Medical Technologies, Inc. is currently considered overvalued and financially unhealthy, with a negative Return on Equity of -1169.69% and a year-to-date stock performance decline of -96.82%, significantly underperforming its peers and the S&P 500.

As of 12 August 2020, Helius Medical Technologies, Inc. has moved from a grade of risky to does not qualify, indicating significant concerns regarding its financial health. The company is currently considered overvalued, particularly given its negative financial ratios. Notably, the Price to Book Value stands at 0.45, while both the EV to EBIT and EV to EBITDA ratios are at 0.04, reflecting a lack of profitability. The Return on Equity (ROE) is alarmingly low at -1169.69%, which underscores the company's struggle to generate returns for shareholders.<BR><BR>In comparison to its peers, Helius Medical Technologies shows a stark contrast with companies like Seastar Medical Holding Corp. and BioRestorative Therapies, which also do not qualify but have less severe financial metrics. The overall peer comparison indicates that Helius is lagging significantly behind, with a valuation of -0.0109 for its EV to EBITDA ratio, compared to peers that are also in the negative range but not as extreme. Furthermore, the company's stock performance has been dismal, with a year-to-date return of -96.82%, starkly underperforming the S&P 500's 2.44% return in the same period.

Read More

Is Helius Medical Technologies, Inc. technically bullish or bearish?

20-Sep-2025

As of July 14, 2025, Helius Medical Technologies, Inc. shows a mildly bearish trend, with daily moving averages indicating bearishness, while weekly and monthly MACD readings are mildly bullish, despite significant underperformance against the S&P 500 with a year-to-date return of -95.39%.

As of 14 July 2025, the technical trend for Helius Medical Technologies, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating a bearish trend, while weekly and monthly MACD readings are mildly bullish. However, the overall sentiment is tempered by the Bollinger Bands and KST showing mildly bearish and bearish signals respectively on the monthly timeframe. Despite the bullish signals in the On-Balance Volume, the stock has significantly underperformed against the S&P 500, with a year-to-date return of -95.39% compared to the S&P 500's 12.22%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 6 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.01

stock-summary
Return on Equity

-256.09%

stock-summary
Price to Book

1.05

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-10 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-28.69%
0%
-28.69%
6 Months
-97.61%
0%
-97.61%
1 Year
-99.15%
0%
-99.15%
2 Years
-99.91%
0%
-99.91%
3 Years
1348.28%
0%
1348.28%
4 Years
-100.0%
0%
-100.0%
5 Years
-100.0%
0%
-100.0%

Helius Medical Technologies, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Helius Medical Technologies, Inc. technically bullish or bearish?

As of 14 July 2025, the technical trend for Helius Medical Technologies, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating a bearish trend, while weekly and monthly MACD readings are mildly bullish. However, the overall sentiment is tempered by the Bollinger Bands and KST showing mildly bearish and bearish signals respectively on the monthly timeframe. Despite the bullish signals in the On-Balance Volume, the stock has significantly underperformed against the S&P 500, with a year-to-date return of -95.39% compared to the S&P 500's 12.22%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-7.97%
EBIT Growth (5y)
4.18%
EBIT to Interest (avg)
-16.83
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.87
Sales to Capital Employed (avg)
0.23
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
6.42%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.45
EV to EBIT
0.04
EV to EBITDA
0.04
EV to Capital Employed
-0.53
EV to Sales
-0.53
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-1169.69%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 3 Schemes (0.84%)

Foreign Institutions

Held by 8 Foreign Institutions (0.02%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs -100.00% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -157.89% vs 2.56% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.30",
          "val2": "-4.00",
          "chgp": "17.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.00",
          "val2": "0.10",
          "chgp": "-6,100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-9.80",
          "val2": "-3.80",
          "chgp": "-157.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-77,255.80%",
          "val2": "-81,857.10%",
          "chgp": "460.13%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -16.67% vs -25.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -31.46% vs 36.88% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.50",
          "val2": "0.60",
          "chgp": "-16.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-13.80",
          "val2": "-12.10",
          "chgp": "-14.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.90",
          "val2": "2.80",
          "chgp": "3.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.70",
          "val2": "-8.90",
          "chgp": "-31.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-26,659.60%",
          "val2": "-19,051.20%",
          "chgp": "-760.84%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-3.30
-4.00
17.50%
Interest
0.60
0.00
Exceptional Items
-6.00
0.10
-6,100.00%
Consolidate Net Profit
-9.80
-3.80
-157.89%
Operating Profit Margin (Excl OI)
-77,255.80%
-81,857.10%
460.13%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.00% vs -100.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -157.89% vs 2.56% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.50
0.60
-16.67%
Operating Profit (PBDIT) excl Other Income
-13.80
-12.10
-14.05%
Interest
0.00
0.00
Exceptional Items
2.90
2.80
3.57%
Consolidate Net Profit
-11.70
-8.90
-31.46%
Operating Profit Margin (Excl OI)
-26,659.60%
-19,051.20%
-760.84%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -16.67% vs -25.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -31.46% vs 36.88% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Helius Medical Technologies, Inc. stock-summary
stock-summary
Helius Medical Technologies, Inc.
Pharmaceuticals & Biotechnology
Helius Medical Technologies, Inc. is a medical technology company focused on neurological wellness. The Company focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain's ability to heal itself. The Company’s offered product is portable neuromodulation stimulator (PoNS) device. PoNS is an authorized class II, non-implantable, medical device in Canada intended for use as a short-term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury (mmTBI) and is to be used in conjunction with physical therapy. The PoNS device is developed to deliver to the tongue a non-invasive neurostimulation, in a form that induces neuromodulation.
Company Coordinates stock-summary
Company Details
642 Newtown Yardley Road , NEWTOWN PA : 18940
stock-summary
Tel: 1 215 9446104
stock-summary
https://heliusmedical.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."